Drug
Niacin clinical trials
Also written Niaspan, Nicotinic acid and Niacor.
- studies test it
- 110
- open now
- 10
- in phase 3
- 26
- first study started
- 2001
Keep track of what changes. Save the Niacin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Combined with it in one product
Studies by the year they started
106 studies that test it; most in 2007 (10)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 9 |
| 2011 | 6 |
| 2012 | 6 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 6
- Phase 1
- 11
- Phase 2
- 22
- Phase 3
- 26
- Phase 4
- 26
- No phase
- 24
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 85
Merck Sharp & Dohme LLC (12) · Université de Sherbrooke (5) · University of Pennsylvania (5) · Kos Pharmaceuticals (4) · Sanofi (3) · University of Washington (3) · Mayo Clinic (2) · Organon and Co (2)
Often tested with
Tested in the same studies.
MK-0524 (20) · Fenofibrate (9) · Simvastatin (7) · Niacinamide (7) · Atorvastatin (7) · Ezetimibe (6) · Lovastatin (6) · Alirocumab (3)
Studies
Open first, then newest update. How each study uses Niacin is read from its arms, and is right about nine times in ten.
Testing it · 110
- Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.RecruitingNot applicableUniversité de SherbrookeNCT06843148Written as Niacin (250mg)
- Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer PatientsRecruitingPhase 1Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07119996Written as Tislelizumab, Cisplatin, Gemcitabine and Vitamin B3
- 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderRecruitingPhase 2Johns Hopkins UniversityNCT05452772Written as Niacin
- Pathways of Eicosanoid MetabolismEnrolling by invitationEarly Phase 1Vanderbilt UniversityNCT04464070Written as niacin
- Regulation of Endogenous Glucose Production by Central KATP ChannelsRecruitingPhase 2Albert Einstein College of MedicineNCT03540758Written as Nicotinic acid
- A Study of Niacin RegulationRecruitingEarly Phase 1Mayo ClinicNCT06175403Written as Niacin
- Nicotinic Acid for the Treatment of Alzheimer's DiseaseRecruitingPhase 1/2Indiana UniversityNCT06582706Written as Extended Release Niacin
- Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric SurgeryRecruitingNot applicableUniversité de SherbrookeNCT05934409Written as Nicotinic Acid
- The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This ResponseRecruitingEarly Phase 1Beth Israel Deaconess Medical CenterNCT06983730Written as Vitamin B3
- Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis PatientsEnrolling by invitationPhase 2/3Al-Azhar UniversityNCT06406140Written as Niacin tablets 500 mg
- Study of Niacin in GlioblastomaActive, not recruitingPhase 1/2AHS Cancer Control AlbertaNCT04677049Written as Niacin CRT
- Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke RecoveryTerminatedPhase 2Henry Ford Health SystemNCT00796887Written as Extended-Release Niacin
- Brown Adipose Tissue Metabolism in Type 2 DiabetesCompletedNot applicableUniversité de SherbrookeNCT05092945Written as Oral Nicotinic acid
- Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe MigraineCompletedPhase 2Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshNCT05846373Written as Nicotinic Acid 500 MG Extended Release Oral Tablet
- Glycogen and AppetiteCompletedNot applicableUniversity of BathNCT05417659Written as Exercise plus niacin
- Effects of Niacin Therapy on Lipoprotein Composition and FunctionCompletedNot applicableNational Heart, Lung, and Blood Institute (NHLBI)NCT02322203Written as Niacin Extended Release
- Low Dose Niacin (Vitamin B3) for Parkinson's DiseaseTerminatedNot applicableVA Office of Research and DevelopmentNCT03808961Written as Niacin
- Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)CompletedNot applicableUniversité de SherbrookeNCT02808182Written as Nicotinic acid
- Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes MellitusCompletedEarly Phase 1Mayo ClinicNCT03867500Written as Niacin
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)CompletedPhase 3Organon and CoNCT00271817Written as Comparator: ezetimibe/simvastatin + niacin (ER)
See all 110 studies that test Niacin →
Given in every arm · 7 — Niacin is usual care beside what is tested
- Biosynthesis of PGD2 in VivoCompletedNot applicableUniversity of PennsylvaniaNCT01275300Written as Niacin
- Visual Surround Suppression and Perceptual Expectation Under PsilocybinTerminatedPhase 1University of MinnesotaNCT04424225Written as Niacin
- PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)TerminatedPhase 1Karyopharm Therapeutics IncNCT02702492Written as Niacin ER
- Psilocybin Cancer Anxiety StudyCompletedEarly Phase 1NYU Langone HealthNCT00957359Written as Niacin
- Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic SyndromeCompletedNot applicableNational Research Council, SpainNCT02061267Written as Niacin
- Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDLCompletedPhase 2University of PennsylvaniaNCT00300365Written as Niacin ER
- Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With DyslipidemiaCompletedPhase 3AbbottNCT00626392Written as niacin extended-release (NER)
As the comparator · 8 — what is tested is compared with Niacin
- Psilocybin Therapy in Advanced CancerRecruitingPhase 2/3NYU Langone HealthNCT05398484Written as Niacin 100mg
- Comparisons of NAD Precursors for Neuroenhancement in Glaucoma PatientsRecruitingPhase 2Christopher Kai Shun LeungNCT06991712Written as Nicotinic Acid
- MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress DisorderRecruitingPhase 2University of SydneyNCT05709353Written as Niacin
- A Study of Psilocybin for Major Depressive Disorder (MDD)CompletedPhase 2Usona InstituteNCT03866174Written as Niacin
- The Effect of Psilocybin on MDD Symptom Severity and Synaptic DensityCompletedPhase 2Section for Affective Disorders; Northern Stockholm PsychiatryNCT04630964Written as Niacin
- Study to Test GSK256073 in Patients With DyslipidemiaCompletedPhase 2GlaxoSmithKlineNCT00903617Written as Niaspan
- Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)CompletedPhase 4SanofiNCT02642159Written as Nicotinic acid
- Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed ConditionsCompletedPhase 1Cortria CorporationNCT01809301Written as Niaspan
Codes
What other systems call Niacin · ClinicalTrials.gg INT007883
- MeSH (NLM) D009525NiacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2679MF687ANIACINConfirmed FDA, NLM
- RxNorm 7393One source FDA
- NCI Thesaurus C689NiacinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009525 | Niacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2679MF687A | NIACIN | Confirmed FDA, NLM |
| RxNorm | 7393 | — | One source FDA |
| NCI Thesaurus | C689 | Niacin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.